Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (173) 173
Book / eBook (52) 52
Publication (32) 32
Dissertation (23) 23
Newspaper Article (20) 20
Paper (15) 15
Book Chapter (5) 5
Conference Proceeding (3) 3
Book Review (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (93) 93
index medicus (74) 74
female (47) 47
male (45) 45
middle aged (28) 28
adult (27) 27
research (24) 24
health aspects (23) 23
pediatrics (23) 23
analysis (22) 22
article (21) 21
history (19) 19
risk factors (18) 18
abridged index medicus (16) 16
care and treatment (16) 16
experiment (15) 15
medicine (15) 15
particle physics (15) 15
aged (14) 14
animals (14) 14
high energy physics - experiment (14) 14
united states (14) 14
clinical trials (13) 13
electronic books (13) 13
physics (13) 13
studies (13) 13
adolescent (12) 12
infants (12) 12
treatment outcome (12) 12
infant, newborn (11) 11
internal medicine (11) 11
physics - high energy physics - experiment (11) 11
science (11) 11
time factors (11) 11
children (10) 10
genetics & heredity (10) 10
surgery (10) 10
young adult (10) 10
aufsatzsammlung (9) 9
cancer (9) 9
high energy physics (9) 9
infant (9) 9
mortality (9) 9
public, environmental & occupational health (9) 9
social conditions (9) 9
therapy (9) 9
women (9) 9
child (8) 8
genetic aspects (8) 8
genetics (8) 8
health (8) 8
management (8) 8
mutation (8) 8
neurosciences (8) 8
nursing (8) 8
physics of elementary particles and fields (8) 8
research article (8) 8
transplantation (8) 8
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (7) 7
diabetes (7) 7
disease (7) 7
education (7) 7
endocrinology & metabolism (7) 7
gene expression (7) 7
medicine, general & internal (7) 7
methods (7) 7
obesity (7) 7
oncology (7) 7
patients (7) 7
prevention (7) 7
prospective studies (7) 7
psychology (7) 7
risk assessment (7) 7
surveys and questionnaires (7) 7
united states - epidemiology (7) 7
usage (7) 7
age (6) 6
brain (6) 6
drug therapy (6) 6
genes (6) 6
genetic research (6) 6
genomes (6) 6
hiv (6) 6
large hadron collider (6) 6
medical research (6) 6
morbidity (6) 6
multidisciplinary sciences (6) 6
multiple sclerosis (6) 6
proteins (6) 6
public health (6) 6
quality of life (6) 6
social sciences (6) 6
software (6) 6
american history (5) 5
biography (5) 5
biology (5) 5
bronchopulmonary dysplasia (5) 5
cardiac & cardiovascular systems (5) 5
child, preschool (5) 5
clinical neurology (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (25) 25
UofT at Mississauga - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Gerstein Science - Stacks (8) 8
UTL at Downsview - May be requested (6) 6
UofT at Scarborough - Stacks (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Faculty of Information - Stacks (2) 2
OISE - Stacks (2) 2
Victoria University E.J. Pratt - Reference (2) 2
Art - Library use only (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Innis College - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Reserve desk (1) 1
Law (Bora Laskin) - Stacks (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Library use only (1) 1
Royal Ontario Museum - Far Eastern West Asian (1) 1
Royal Ontario Museum - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Reference Desk (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
by Cohen, Jeffrey A, Prof and Coles, Alasdair J, PhD and Arnold, Douglas L, Prof and Confavreux, Christian, Prof and Fox, Edward J, MD and Hartung, Hans-Peter, Prof and Havrdova, Eva, Prof and Selmaj, Krzysztof W, Prof and Weiner, Howard L, Prof and Fisher, Elizabeth, PhD and Brinar, Vesna V, MD and Giovannoni, Gavin, Prof and Stojanovic, Miroslav, MD and Ertik, Bella I, MD and Lake, Stephen L, ScD and Margolin, David H, MD and Panzara, Michael A, MD and Compston, D Alastair S, Prof and CARE-MS I Investigators and CARE-MS I investigators
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9856, pp. 1819 - 1828
Summary Background The anti-CD52 monoclonal antibody alemtuzumab reduced disease activity in a phase 2 trial of previously untreated patients with... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPEUTIC LYMPHOCYTE DEPLETION | MULTICENTER | FUNCTIONAL COMPOSITE | INTRAMUSCULAR INTERFERON | MS | DISABILITY | FOLLOW-UP | ANTIBODY | GLATIRAMER ACETATE | THYROID-NODULES | Interferon-beta - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Recurrence | Adjuvants, Immunologic - administration & dosage | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Administration, Cutaneous | Alemtuzumab | Adjuvants, Immunologic - adverse effects | Young Adult | Disease-Free Survival | Antibodies, Monoclonal, Humanized - administration & dosage | Interferon beta-1a | Interferon-beta - adverse effects | Adolescent | Adult | Female | Infusions, Intravenous | Complications and side effects | Multiple sclerosis | Dosage and administration | Research | Drug therapy | Fees & charges | Biomedical research | Lymphocytes | Compensation | Interferon | Pharmaceutical industry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Measurement and clinical effect of grey matter pathology in multiple sclerosis
by Geurts, Jeroen JG, Prof and Calabrese, Massimiliano, MD and Fisher, Elizabeth, PhD and Rudick, Richard A, Prof
Lancet Neurology, ISSN 1474-4422, 2012, Volume 11, Issue 12, pp. 1082 - 1092
Summary During the past 10 years, the intense involvement of the grey matter of the CNS in the pathology of multiple sclerosis has become evident. On gross... 
Neurology | INTRACORTICAL LESIONS | BRAIN ATROPHY | INVERSION-RECOVERY | WHITE-MATTER | EPSTEIN-BARR-VIRUS | CEREBRAL-CORTEX | MS PATIENTS | CLINICAL NEUROLOGY | CORTICAL LESION DETECTION | DISABILITY PROGRESSION | VOLUME CHANGES | Multiple Sclerosis - psychology | Multiple Sclerosis - diagnosis | Animals | Humans | Cerebral Cortex - pathology | Multiple Sclerosis - pathology | Clinical Trials as Topic - methods | Measurement | Brain damage | Neurosciences | Multiple sclerosis | Atrophy | Neuroimaging | Brain | Image processing | Magnetic resonance imaging | Demyelination | Central nervous system | Substantia alba | Substantia grisea
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
by Coles, Alasdair J, Dr and Twyman, Cary L, MD and Arnold, Douglas L, Prof and Cohen, Jeffrey A, Prof and Confavreux, Christian, Prof and Fox, Edward J, MD and Hartung, Hans-Peter, Prof and Havrdova, Eva, Prof and Selmaj, Krzysztof W, Prof and Weiner, Howard L, Prof and Miller, Tamara, MD and Fisher, Elizabeth, PhD and Sandbrink, Rupert, MD and Lake, Stephen L, ScD and Margolin, David H, MD and Oyuela, Pedro, MD and Panzara, Michael A, MD and Compston, D Alastair S, Prof and CARE-MS II Investigators and CARE-MS II investigators
Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Summary Background The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple... 
Internal Medicine | MONOCLONAL-ANTIBODY TREATMENT | OUTCOME MEASURE | CAMPATH-1H | TESTS | MEDICINE, GENERAL & INTERNAL | CLINICAL-TRIAL | FUNCTIONAL COMPOSITE | INTERFERON-BETA | RECONSTITUTION | LYMPHOCYTE DEPLETION | Antibodies, Monoclonal, Humanized - adverse effects | Recurrence | Adjuvants, Immunologic - administration & dosage | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Glatiramer Acetate | Male | Treatment Outcome | Administration, Cutaneous | Alemtuzumab | Peptides - administration & dosage | Adjuvants, Immunologic - adverse effects | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Adolescent | Adult | Female | Immunosuppressive Agents - adverse effects | Infusions, Intravenous | Immunosuppressive Agents - administration & dosage | Peptides - adverse effects | Drug therapy | Multiple sclerosis | Medical research | Interferon
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States
by Linton, Sabriya L., PhD, MPH and Cooper, Hannah L.F., ScD and Kelley, Mary E., PhD and Karnes, Conny C., MA and Ross, Zev, MS and Wolfe, Mary E., MPH and Chen, Yen-Tyng, PhD and Friedman, Samuel R., PhD and Des Jarlais, Don, PhD and Semaan, Salaam, DrPH and Tempalski, Barbara, PhD, MPH and Sionean, Catlainn, PhD and DiNenno, Elizabeth, PhD and Wejnert, Cyprian, PhD and Paz-Bailey, Gabriela, MD, PhD and Natl HIV Behav Surveillance Study and National HIV Behavioral Surveillance Study Group
Annals of Epidemiology, ISSN 1047-2797, 2016, Volume 26, Issue 9, pp. 619 - 630.e2
Abstract Purpose Investigate whether characteristics of geographic areas are associated with condomless sex and injection-related risk behavior among... 
Internal Medicine | Injection drug use | HIV | Drug treatment | PWID | Condom use | HCV | Housing | RACIAL RESIDENTIAL SEGREGATION | STERILE SYRINGES | SURVEILLANCE SYSTEM | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | US METROPOLITAN-AREAS | NEW-YORK-CITY | SAN-FRANCISCO | C VIRUS-INFECTIONS | SYRINGE EXCHANGE PROGRAMS | LONGITUDINAL ANALYSIS | SEXUAL RISK | Geography | Ethnic Groups - statistics & numerical data | United States - epidemiology | Sexual Behavior | Risk Assessment | HIV Infections - epidemiology | Humans | Patient Safety - statistics & numerical data | Substance Abuse, Intravenous - epidemiology | HIV Infections - psychology | Male | Communicable Disease Control - methods | Incidence | Young Adult | Health Surveys | Risk-Taking | Adult | Female | Hepatitis C, Chronic - epidemiology | Hepatitis C, Chronic - psychology | Continental Population Groups - statistics & numerical data | Needs Assessment | Drugs | HIV (Viruses) | Hepatitis C virus | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Effect of coastal marine protection on childhood health: an exploratory study
by Fisher, Brendan, Dr and Herrera, Diego, PhD and Adams, Diane, PhD and Fox, Helen E, PhD and Gill, David A, PhD and Golden, Christopher D, PhD and Mulligan, Mark, PhD and Myers, Samuel S, MD MPH and Pfaff, Alexander, Prof and Selig, Elizabeth R, PhD and Ricketts, Taylor H, Prof
Lancet, The, ISSN 0140-6736, 2017, Volume 389, pp. S8 - S8
Abstract Background The integrity of ocean ecosystems are currently under threat from a suite of anthropogenic drivers including climate change, over-fishing,... 
Internal Medicine | Protection and preservation | Developing countries | Global temperature changes | Fishing | Environmental economics | Environmental health | Marine resources conservation | Analysis | Protected areas | Climate | Populations | Logit models | Climatic data | Human influences | Childrens health | Conservation | Economic factors | Social factors | Marine conservation | Biodiversity | Developing countries--LDCs | Coastal ecosystems | Incidence | Degradation | Demographics | Children | Biodegradation | Coasts | Marine protected areas | Oceans | Health | Health risks | Socio-economic aspects | Fisheries | Environmental factors | Resource exploitation | Anthropogenic factors | Children & youth | Climate change | Overfishing | Marine ecosystems | Models | Economic impact | Information theory
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
by Bermel, Robert A and Fisher, Elizabeth and Cohen, Jeffrey A
Neuroimaging Clinics of North America, ISSN 1052-5149, 11/2008, Volume 18, Issue 4, pp. 687 - 701
MR imaging is an integral part of multiple sclerosis (MS) clinical trials. It provides the primary efficacy outcome of preliminary proof-of-concept studies and... 
Clinical trials | Multiple sclerosis | Magnetic resonance imaging | Outcomes | T2 LESION VOLUME | MAGNETIZATION-TRANSFER RATIO | SECONDARY PROGRESSIVE MS | NEUROSCIENCES | NEUROIMAGING | APPEARING WHITE-MATTER | T1-WEIGHTED SPIN-ECHO | DOSE GADOLINIUM-DTPA | PLACEBO-CONTROLLED TRIAL | WHOLE-BRAIN ATROPHY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RELAPSING-REMITTING MS | INTERFERON BETA-1A | Magnetic Resonance Imaging | Predictive Value of Tests | Outcome Assessment (Health Care) | Humans | Atrophy - pathology | Brain - pathology | Multiple Sclerosis - pathology | Clinical Trials as Topic | Atrophy - etiology | Multiple Sclerosis - therapy
Journal Article
Details down arrow
7. Full Text Patient Identification Errors Are Common in a Simulated Setting
by Henneman, Philip L., MD and Fisher, Donald L., PhD and Henneman, Elizabeth A., PhD, RN and Pham, Tuan A., BA and Campbell, Megan M., BSN and Nathanson, Brian H., PhD
Annals of Emergency Medicine, ISSN 0196-0644, 2009, Volume 55, Issue 6, pp. 503 - 509
Study objective We evaluate the frequency and accuracy of health care workers verifying patient identity before performing common tasks. Methods The study... 
Emergency | EMERGENCY MEDICINE | SAFETY | EMERGENCY-DEPARTMENT | Patient Simulation | Prospective Studies | Blood Specimen Collection - standards | Humans | Emergency Medical Services - standards | Emergency Nursing - standards | Medical Errors - statistics & numerical data | Injections, Intravenous - standards | Nurses - standards | Emergency Medical Technicians - standards | Patient Identification Systems - standards
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice
by Liu, Shi-He, MD and Smyth-Templeton, Nancy, PhD and Davis, Alan R., PhD and Davis, Elizabeth A., PhD and Ballian, Nikiforos, MD and Li, Min, PhD and Liu, Hao, PhD and Fisher, William, MD and Brunicardi, F. Charles, MD
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2011, Volume 149, Issue 4, pp. 484 - 495
Background Adenoviral gene therapy has been applied widely for cancer therapy; however, transient gene expression as result of humoral immunoneutralization... 
Surgery | THYMIDINE KINASE | SURGERY | IMMUNE-RESPONSE | TUMOR-MODEL | IN-VITRO | ANTITUMOR-ACTIVITY | PHASE-I | VECTORS | REDUCES VIRAL ANTIGENICITY | DELIVERY | P53 | Diabetes Mellitus - pathology | Pancreatic Neoplasms - metabolism | Liposomes - administration & dosage | Homeodomain Proteins - metabolism | Humans | Male | Immunity, Humoral | Diabetes Mellitus - etiology | Adenoviridae - immunology | Promoter Regions, Genetic | Islets of Langerhans - pathology | Thymidine Kinase - genetics | Mice, Inbred C57BL | Rats | Thymidine Kinase - administration & dosage | Tumor Burden | Mice, SCID | Antiviral Agents - administration & dosage | Mice, Inbred ICR | Xenograft Model Antitumor Assays | Animals | Thymidine Kinase - metabolism | Cell Line, Tumor | Carcinoma - therapy | Trans-Activators - metabolism | Mice | Carcinoma - metabolism | Genetic Vectors | Antibodies, Neutralizing - blood | Ganciclovir - administration & dosage | Apoptosis | Genetic Therapy - adverse effects | Genetic Therapy - methods | Pancreatic Neoplasms - therapy | Ganciclovir | Care and treatment | Pancreatic cancer | Adenoviruses | Genetic research | Genetic aspects | Gene expression | Gene therapy | Health aspects | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Myxofibrosarcomas contain large numbers of infiltrating immature dendritic cells
by Soilleux, Elizabeth J and Rous, Brian and Love, Karl and Vowler, Sarah and Morris, Lesley S and Fisher, Cyril and Coleman, Nicholas
American journal of clinical pathology, ISSN 0002-9173, 04/2003, Volume 119, Issue 4, pp. 540 - 545
Myxofibrosarcoma is a malignant tumor with distinctive histologic features and is believed to be derived from fibroblasts. The function of infiltrating myeloid... 
Histiocytoma, Benign Fibrous - metabolism | Cell Count | Humans | Dendritic Cells - pathology | Receptors, Cell Surface - metabolism | Fibrosarcoma - metabolism | Cell Adhesion Molecules - metabolism | Myosarcoma - metabolism | Immunoenzyme Techniques | Lectins, C-Type - metabolism | Fibrosarcoma - pathology | Myosarcoma - pathology | Histiocytoma, Benign Fibrous - pathology | Biomarkers, Tumor - metabolism | Dendritic Cells - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text We Are What We Do
by Sanson-Fisher, Rob W., PhD and Campbell, Elizabeth M., PhD and Htun, Aye Thidar, MBBS and Bailey, Laura J., BPsyc and Millar, Cynthia J., BSc
American Journal of Preventive Medicine, ISSN 0749-3797, 2008, Volume 35, Issue 4, pp. 380 - 385
Background If public health research does not progress beyond descriptive research to testing the effectiveness of interventions that can provide causal data,... 
Internal Medicine | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Improved Cuff Technique and Intraoperative Detection of Vascular Complications for Hind Limb Transplantation in Mice
by Kim, Minhyung and Fisher, Daniel T and Powers, Colin A and Repasky, Elizabeth A and Skitzki, Joseph J
Transplantation direct, ISSN 2373-8731, 02/2018, Volume 4, Issue 2, p. e345
Vascularized composite tissue allotransplantation (VCA) from a cadaveric donor has now become a clinical reality and the treatment modality of choice for... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights